Inlay

Profile

1 week left to support @danafarber.bsky.social & Gronk Nation Youth Foundation! Help us finish strong + take on @RobGronkowski! 🎟️ $187+ = ticket to the event 🏈 $100+ = chance to win signed Gronk football 👀 Gronk, Edelman, Ninkovich, Chung 📅 Deadline: May 20 🔗 charity.pledgeit.org/pickleball/t...

May 14, 2025

Toni Choueiri, MD

“I can imagine no heroism greater than motherhood." - Happy Mothers day mom and all the mothers in the world ! #HappyMothersDay2025

Thank you @theaacr.bsky.social for this honor !

Our own @danafarber.bsky.social Dr. @NarjustFlorezMD is running for @iaslc.bsky.social Board. Let us support NJ! @narjustflorezmd.bsky.social @danafarbernews.bsky.social

Thank you @theaacr.bsky.social for the Waun Ki Hong Award! My talk will be addressing Precision Medicine in Renal Cell Carcinoma. See you in Chicago! cc: @danafarber.bsky.social

May 11, 2025

Apr 14, 2025

Apr 19, 2025

Apr 25, 2025

Toni Choueiri, MD

Empowering Oncologists: How far can purpose and passion take you in cancer care? @drchoueiri.bsky.social oncodaily.com/dialogues/31... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EmpoweringOncologists

We’re getting ready to wrap up #AACR25 today, but not before once again congratulating @danafarbernews.bsky.social’s Matthew Meyerson, MD, PhD, FAACR, @drchoueiri.bsky.social and Alice T. Shaw, MD, PhD, for receiving @theaacr.bsky.social 2025 Scientific Achievement Awards. bit.ly/4j7m8om

Toni Choueiri, MD

11mo

Apr 30, 2025

@drchoueiri.bsky.social‬ discusses promising results from the phase 1 ARC-20 study, exploring the combination of Casdatifan and cabozantinib in patients with previously treated clear cell renal cell carcinoma. #ASCO25

Jun 1, 2025

“Our focused efforts are yielding results that are helping patients today and guiding our research towards more advances in the future,” says @drchoueiri.bsky.social. Learn about the research advancements our Lank Center for Genitourinary Oncology has made this past year.

In 2023, the @fda.gov approved belzutifan for certain kidney cancers –– thanks to years of work led by Nobel Prize recipient William G. Kaelin Jr., MD. Now, @drchoueiri.bsky.social, director of our Lank Center for Genitourinary Oncology, and team are working to expand its clinical use.

Apr 11, 2025

Jun 5, 2025

OncoDaily

Dana-Farber News

Dana-Farber Cancer Institute

We're excited to join this incredible initiative! This organization's mission is very important to us and we're proud to help them make a difference. Please support us by giving to our page. Every dol...

charity.pledgeit.org

Support Kancer Killers - Pickleball for a Purpose 2025

Empowering Oncologists: How far can purpose and passion take you in cancer care? / cancer, Empowering Oncologists, Jasmine Kamboj, OncoDaily, Oncology, Toni

oncodaily.com

Empowering Oncologists: How far can purpose and passion take you in cancer care? - OncoDaily

Basic science discoveries made by Dana-Farber's William G. Kaelin Jr., MD, and his colleagues are propelling powerful new therapies for kidney cancer.

bit.ly

Chain Reaction: The Belzutifan Journey | Dana-Farber Cancer Institute

Published: February 6, 2025Written by: Beth DoughertyMedically Reviewed By: Atish Choudhury, MD, PhD, Toni Choueiri, MD, and Mark Pomerantz, MDDana-Farber’s genitourinary cancer team is devoted to res...

bit.ly

A Year of Advances in Genitourinary Cancer

Congratulations to @danafarbernews.bsky.social’s Matthew Meyerson, MD, PhD, FAACR, @drchoueiri.bsky.social, and Alice T. Shaw, MD, PhD, recipients of @theaacr.bsky.social 2025 Scientific Achievement Awards. bit.ly/4j7m8om

Apr 14, 2025

Dana-Farber News